Public Profile

Eli Lilly and Company

Eli Lilly and Company, commonly referred to as Lilly, is a global leader in the pharmaceutical industry, headquartered in the United Kingdom. Founded in 1876, the company has established a strong presence in major operational regions, including North America, Europe, and Asia, focusing on innovative solutions in diabetes, oncology, immunology, and neuroscience. Lilly is renowned for its pioneering products, such as insulin therapies and cancer treatments, which are distinguished by their commitment to research and development. The company has achieved significant milestones, including the introduction of groundbreaking medications that have transformed patient care. With a robust market position, Eli Lilly continues to be recognised for its contributions to healthcare, consistently ranking among the top pharmaceutical companies worldwide.

DitchCarbon Score

How does Eli Lilly and Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

55

Industry Average

Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

25

Industry Benchmark

Eli Lilly and Company's score of 55 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.

98%

Let us know if this data was useful to you

Eli Lilly and Company's reported carbon emissions

In 2023, Eli Lilly and Company reported total carbon emissions of approximately 182,000,000 kg CO2e for Scope 1, 345,000,000 kg CO2e for Scope 2, and 5,139,500,000 kg CO2e for Scope 3, bringing their total emissions to about 5,666,500,000 kg CO2e. The company has set an ambitious target to achieve carbon neutrality in its operations by 2030, encompassing all scopes of emissions. This commitment reflects Lilly's dedication to reducing its carbon footprint and addressing climate change proactively. In previous years, emissions have shown fluctuations, with 2022 emissions recorded at approximately 171,000,000 kg CO2e for Scope 1, 374,000,000 kg CO2e for Scope 2, and 5,139,500,000 kg CO2e for Scope 3. The company has consistently disclosed emissions across all three scopes, demonstrating transparency in its environmental impact reporting. Eli Lilly's ongoing initiatives and targets align with industry standards for climate action, reinforcing its commitment to sustainability and responsible corporate practices.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

200720102011201220132014201820192020202120222023
Scope 1
527,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
1,310,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
14,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
000,000,000
000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Eli Lilly and Company's primary industry is Other services (93), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Eli Lilly and Company is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Eli Lilly and Company is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Lundbeck

DK
Health and social work services (85)
Updated 4 days ago

Novartis Pharmaceuticals Corporation

US
Chemicals nec
Updated 3 months ago
DitchCarbon Score

Johnson And Johnson

US
Chemicals nec
Updated 4 days ago

Novartis

CH
Chemicals nec
Updated 4 days ago

Wyeth LLC

US
Chemicals nec
Updated 3 months ago
DitchCarbon Score

Bayer

DE
Chemicals nec
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers